Determinants of bumetanide response in the dog: effect of probenecid.
The pharmacokinetics and pharmacodynamics of intravenous bumetanide (0.250 mg/kg), alone (treatment I) and after probenecid pretreatment (treatment II), were studied in four mongrel dogs. Lactated Ringer's solution was administered by vein throughout both treatments at a flow rate of 2 ml/min to avoid fluid and electrolyte depletion. Bumetanide and probenecid concentrations were analyzed by HPLC, sodium by flame photometry, and creatinine by colorimetry. Although the probenecid markedly reduced the plasma and renal clearances of bumetanide, as well as the fraction excreted unchanged in the urine, there was no significant difference between treatments I and II in the 4-hr natriuretic and diuretic responses. However, analysis of the dose-response curves between treatments I and II showed that sodium excretion was better correlated with bumetanide urinary excretion rate than with plasma concentration. The reasons for a poor correlation between treatments during the early time periods are discussed.
D000818:Animals; D002034:Bumetanide / Q000008:administration & dosage* / Q000378:metabolism; D004231:Diuresis / Q000187:drug effects; D004232:Diuretics / Q000008:administration & dosage*; D004285:Dogs; D004347:Drug Interactions; D007668:Kidney / Q000378:metabolism; D007700:Kinetics; D008297:Male; D009318:Natriuresis / Q000187:drug effects; D011339:Probenecid / Q000008:administration & dosage* / Q000378:metabolism
D004232:Diuretics; D002034:Bumetanide; D011339:Probenecid